Articles in Press

Final Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation (JCOPDF) manuscripts are published and available in our Articles in Press section as soon as possible following editorial acceptance. These articles have completed both a rigorous peer review process and a thorough copyediting/editorial acceptance phase. Quarterly, these articles will be compiled into formal issues along with editorials, correspondence and additional themed reviews and features. To receive notifications of the posting of new Articles in Press AND the posting of new JCOPDF issues, sign up for a free subscription here.

Symptomatic Changes Associated With a Pharmacist-Led COPD Program

Edward C. Portillo, PharmD^1,2 Steven Do, PharmD^1,2,3 Scott Hetzel, MS⁴ Jennifer Nguyen¹ Katelynn Cleveland, MS¹Cara Ray, PhD⁵ Jenna Vande Hey¹ Pramit Maskey, MS⁶ Rena Steiger-Chadwick, MPH⁵ Lucas M. Donovan, MD, MS⁷ Dylan Erdelt¹ Sarah Will, PharmD, BCPS⁸ Michael Shawn McFarland, PharmD, FCCP, BCACP⁸ Heather Ourth, PharmD, BCPS, BCGP, FASHP⁸ Michelle Chui, PharmD, PhD⁹

Citation: Portillo EC, Do S, Hetzel S, et al. Symptomatic changes associated with a pharmacist-led COPD program. Chronic Obstr Pulm Dis. 2026; Published online April 16, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0716

View Pre-proof PDF

Small Pulmonary Artery and Vein Volumes Independently Predict Oxygen Desaturation in Smokers

Anastasia K. A. L. Kwee¹ Wouter A. C. van Amsterdam² Firdaus A. A. Mohamed Hoesein¹ Leticia Gallardo-Estrella³ Jean-Paul Charbonnier³ Stephen M. Humphries⁴ Harm A. W. M. Tiddens³ James D. Crapo⁵ Richard Casaburi^6,7 Pim A. de Jong¹ David A. Lynch⁴ Esther Pompe¹

Citation: Kwee AKWL, van Amsterdam WAC, Mohamed Hoesein FAA, et al. Small pulmonary artery and vein volumes independently predict oxygen desaturation in smokers. Chronic Obstr Pulm Dis. 2026; Published online April 10, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0694

View Pre-proof PDF

Reconsidering Vitamin D Supplementation in Pulmonary Disease: The Case for Targeted Respiratory Delivery

Kevin D. Schichlein¹ Ilona Jaspers² M. Bradley Drummond³

Citation: Schichlein KD, Jaspers I, Drummond MB. Reconsidering vitamin D supplementation in pulmonary disease: the case for targeted respiratory delivery. Chronic Obstr Pulm Dis. 2026; Published online March 31, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0713

View Pre-proof PDF

Clinical Significance of Reduced Forced Expiratory Volume in 3 Seconds to Forced Expiratory Volume in 6 Seconds in Adults

Siman Liao, MD^1* Juncheng Liang, MD^1* Jie Ou, MD² Ranxi Peng, MD³ Shiyu Zhang, MD⁴ Leheng Tang, MD⁴ Qiaorui Zhou, MD⁴ Yingtong Chen, MD⁴ Xiaozi Guo, MD¹ Jingxian Chen, MD¹ Qi Wan, MD⁵ Zihui Wang, MD, PhD⁵ Zhishan Deng, MD, PhD⁵ Yumin Zhou, MD, PhD^5,6 Fan Wu, MD, PhD⁵

Citation: Liao S, Liang J, Ou J, et al. Clinical significance of reduced forced expiratory volume in 3 seconds to forced expiratory volume in 6 seconds in adults. Chronic Obstr Pulm Dis. 2026; Published online March 31, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0649

View Pre-proof PDF

Understanding COPD Patients’ Perspectives on Utilizing Strategies to Limit Their Exposure to Wildfire Smoke

Jimmy Yao, MD, MPH¹ Caitlin M. Lydon, MPH¹ Nina Pak, PhD¹ Kathleen A. Daly, BS¹ Mary Meyer, MD, MPH² Nadia Hansel, MD, MPH³ Mark T. Dransfield, MD⁴ Stacey Alexeeff, PhD¹ Andrea Altshuler, PhD¹ Laura C. Myers, MD, MPH¹

Citation: Yao J, Lydon CM, Pak N, et al. Understanding COPD patients’ perspectives on utilizing strategies to limit their exposure to wildfire smoke. Chronic Obstr Pulm Dis. 2026; Published online March 30, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0682

View Pre-proof PDF

Exploring the Impact of Financial Toxicity in COPD: A Qualitative Study

Sonal G. Mallya, MD, MHS1 Kaila Holloway, MD, MPH2 Cyd K. Eaton, PhD3 Michelle Sharp, MD, MHS1 Nirupama Putcha, MD, MHS1 Kristin A. Riekert, PhD1 Theodore J. Iwashyna, MD, PhD1 Michelle N. Eakin, PhD1

Citation: Mallya SG, Holloway K, Eaton CK, et al. Exploring the impact of financial toxicity in COPD: a qualitative study. Chronic Obstr Pulm Dis. 2026; Published online March 30, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0712

View Pre-proof PDF

Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada

Mohit Bhutani¹ Alan Kaplan² Sheena Kayaniyil³ Kyla Jamieson³ Ross Ormsby³ John Bell⁴ Prachi Bhatt⁵ Jennifer Carioto⁵ Bruce Pyenson⁵

Citation: Bhutani M, Kaplan A, Kayaniyil S, et al. Implementation of 2023 Canadian Thoracic Society guidelines for single-inhaler triple therapy could reduce exacerbation and mortality rates in COPD: PROMETHEUS Canada. Chronic Obstr Pulm Dis. 2026; Published online March 30, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0687

View Pre-proof PDF

Clinical Characteristics and Health Care Resource Utilization Among Individuals Undergoing Alpha-1 Antitrypsin Testing in a Quaternary Health System

Drew D. Robinson, MD^1,2,3 Chia-Ying Chiu, DrPH^1,2 Jane I. Hampton, MD⁴ George M. Solomon, MD^1,5 J. Michael Wells, MD, MSPH^1,2,3,6

Citation: Robinson DD, Chiu CY, Hampton JI, Solomon GM, Wells JM. Clinical characteristics and health care resource utilization among individuals undergoing alpha-1 antitrypsin testing in a quaternary health system. Chronic Obstr Pulm Dis. 2026; Published online March 30, 2026. doi: https://doi.org/10.15326/jcopdf.2025.0723

View Pre-proof PDF

ISSN 2372-952X

Time from submission to first decision:

30 days

Indexed by:

PubMed
PubMed Central
Science Citation Index Expanded
Scopus

The JCOPDF is available free of charge.
Please sign up to receive your free digital subscription.

Author Guidelines

Copyright & Reprints

While the JCOPDF is an open access journal and free access to its content is encouraged, reproduction of JCOPDF content for bulk and commercial distribution/ use must be purchased from the COPD Foundation, sole copyright holder of all JCOPDF content. If you are interested in ordering (or obtaining a quote for) paper reprints or e-prints of an article, please contact scsreprints@sheridan.com. If you wish to request information about reproducing figures or tables, please contact Bethany Hendrix, JCOPDF staff member at bhendrix@copdfoundation.org. Authors should contact the Foundation directly related to their requests for personal use of articles, figures, charts, etc.

The COPD Foundation is a nonprofit, tax-exempt charitable organization under Section 501(c)(3) of the Internal Revenue Code.

Chronic Obstructive Pulmonary Diseases:Journal of the COPD Foundation_®

Articles in Press

Symptomatic Changes Associated With a Pharmacist-Led COPD Program

Small Pulmonary Artery and Vein Volumes Independently Predict Oxygen Desaturation in Smokers

Reconsidering Vitamin D Supplementation in Pulmonary Disease: The Case for Targeted Respiratory Delivery

Clinical Significance of Reduced Forced Expiratory Volume in 3 Seconds to Forced Expiratory Volume in 6 Seconds in Adults

Understanding COPD Patients’ Perspectives on Utilizing Strategies to Limit Their Exposure to Wildfire Smoke

Exploring the Impact of Financial Toxicity in COPD: A Qualitative Study

Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada

Clinical Characteristics and Health Care Resource Utilization Among Individuals Undergoing Alpha-1 Antitrypsin Testing in a Quaternary Health System

Author Guidelines

Copyright & Reprints

COPD Resources for Medical Professionals

Advertising

Resources

Contact Us

Chronic Obstructive Pulmonary Diseases:Journal of the COPD Foundation®

Articles in Press

Symptomatic Changes Associated With a Pharmacist-Led COPD Program

Small Pulmonary Artery and Vein Volumes Independently Predict Oxygen Desaturation in Smokers

Reconsidering Vitamin D Supplementation in Pulmonary Disease: The Case for Targeted Respiratory Delivery

Clinical Significance of Reduced Forced Expiratory Volume in 3 Seconds to Forced Expiratory Volume in 6 Seconds in Adults

Understanding COPD Patients’ Perspectives on Utilizing Strategies to Limit Their Exposure to Wildfire Smoke

Exploring the Impact of Financial Toxicity in COPD: A Qualitative Study

Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada

Clinical Characteristics and Health Care Resource Utilization Among Individuals Undergoing Alpha-1 Antitrypsin Testing in a Quaternary Health System

Author Guidelines

Copyright & Reprints

Chronic Obstructive Pulmonary Diseases:Journal of the COPD Foundation_®